UBS Group AG - ADICET BIO INC ownership

ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 59 filers reported holding ADICET BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ADICET BIO INC
ValueSharesWeighting
Q3 2023$5,942
+8903.0%
4,337
+15963.0%
0.00%
Q2 2023$66
-100.0%
27
-100.0%
0.00%
Q4 2022$1,051,246
+327.3%
117,589
+580.9%
0.00%
Q3 2022$246,000
+2136.4%
17,269
+3057.0%
0.00%
Q1 2022$11,000
-93.6%
547
-94.5%
0.00%
Q4 2021$173,000
+17200.0%
9,885
+6403.3%
0.00%
Q3 2021$1,000
-95.5%
152
-91.0%
0.00%
Q1 2021$22,000
+175.0%
1,693
+194.9%
0.00%
Q4 2020$8,000
-52.9%
574
-59.0%
0.00%
Q3 2020$17,0001,4000.00%
Other shareholders
ADICET BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 728,944$998,6530.37%
DAFNA Capital Management LLC 797,054$1,091,9640.34%
COWEN AND COMPANY, LLC 2,715,278$3,719,9300.26%
Orbimed Advisors 8,322,140$11,401,3320.24%
TANG CAPITAL MANAGEMENT LLC 1,226,352$1,680,1020.24%
Carlyle Group Inc. 2,115,385$2,876,9240.12%
RTW INVESTMENTS, LP 4,241,472$5,810,8170.12%
Acuitas Investments, LLC 136,779$187,3870.11%
Decheng Capital Management III (Cayman), LLC 200,201$274,2750.09%
GSA CAPITAL PARTNERS LLP 142,168$1950.02%
View complete list of ADICET BIO INC shareholders